1) liver transplantation of HCC
肝癌肝移植
1.
[Methods] AFP mRNA in disseminated tumor cells(DTC), matrix metalloproteinase-9 in tumor tissue, serum CD44v6 were quantitated in 30 patients for orthotopic liver transplantation of HCC by fluorescence quantitative PCR combined with RT-PCR technique, ELISA, immunohistoch.
目的探讨肿瘤播散细胞检测对肝癌肝移植术中转移的评价意义以及与基质金属蛋白水解酶(MMP-9)、黏附分子(CD44v6)的相关性。
3) Implanted Hepatoma
移植性肝癌
1.
Influence of Fu-zheng Anti-carcinoma Prescription (FAP) on PCNA Expression and AgNORs in Rats with Implanted Hepatoma;
扶正抗癌方对大鼠移植性肝癌PCNA、AgNORs表达的影响
2.
Therapeutic effect of intravenous high-dose vitamin C on implanted hepatoma in rats
大剂量维生素C治疗大鼠移植性肝癌
4) transplanted liver cancer
移植性肝癌
1.
OBJECTIVE To investigate the blood drug level and pharmacokinetic parameter and to detect the distribution performance of carboplatin-Fe@C-loaded chitosan nanoparticles(C-Fe@C-CN) injected by hepatic artery in rat with transplanted liver cancer.
目的观察卡铂碳包铁纳米笼壳聚糖微球(carboplatin-Fe@C-loaded chitosan nanoparticles,C-Fe@C-CN)结合磁场在移植性肝癌大鼠模型体内的靶向分布情况和药动学过程。
5) transplanted hepatoma
移植型肝癌
1.
Objective To study the effect of combined angiogenesis inhibitor YH-16 with chemoembolization on rat\'s transplanted hepatoma.
目的观察经动脉插管注入血管生成抑制剂YH-16和化疗栓塞联合应用对大鼠移植型肝癌的抑制作用。
6) murine hepatoma H22 liver cancer
H22肝癌移植瘤
1.
Experimental study on the effects of staphylococcal enterotoxin C injection combined with cisplatin on murine hepatoma H22 liver cancer in vivo;
金葡素注射液与顺铂合用对H22肝癌移植瘤作用的实验研究
补充资料：背驮式肝移植
背驮式肝移植
piggyback liver transplantation,PBLT
即为保留受者下腔静脉的原位肝移植。在原位肝移植病肝切除后的无肝期内，常规的方法经阻断肝上、肝下、下腔静脉，引起下肢、肾脏的静脉回流受阻导致全身血流动力学的改变。而保留受者的下腔静脉则可使血流动力学紊乱大为减轻。术中不必采用体外静脉转流术。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条